Catalyst MedTech, a national leader in diagnostic imaging solutions and service, announced today the expansion of its strategic partnership with Arineta, a leader in advancing cardiovascular imaging solutions, to include sales representation of Arineta’s world-class SpotLight™ CT systems in the U.S. market.
Building on an existing relationship through Catalyst’s Propel Partner Program, Catalyst has been providing installation, repair, and maintenance services for Arineta’s cutting-edge single-beat cardiac CT systems for the past two years. The deepened partnership now positions Catalyst as both a technical and commercial partner, with responsibility for supporting Arienta’s North American growth strategy by pursuing and closing sales opportunities, supporting existing qualified leads, and generating new business growth.
“At Catalyst, we don’t just maintain technology—we accelerate it,” said Martin Shirley, President & CEO of Catalyst MedTech. “This expanded relationship with Arineta exemplifies how our Propel Program can unlock untapped potential for OEMs. By leveraging our sales expertise, cardiology market knowledge, and nationwide infrastructure, we’re helping Arineta energize their commercial efforts and bring their revolutionary technology to more customers, faster.”
“Arienta is dedicated to expanding access to lifesaving cardiovascular imaging, and we are excited to extend our partnership with the Catalyst team to accelerate that vision” said Doug Ryan, CEO of Arienta. “Catalyst has been a trusted partner in supporting our installation, upgrades, and customer service programs, and we are pleased to utilize them in an expanded capacity throughout the entire customer lifecycle. This strategic move positions us to meet the growing demand for cardiac CT.”
Arineta’s SpotLight™ and SpotLight™ Duo, the world’s first dedicated cardiovascular and thoracic CT scanners, known for its single-heartbeat cardiac CT angiography technology, delivers innovative solutions that perfectly align with Catalyst’s “yes” culture of enabling advanced diagnostics in cardiology and beyond. This move further deepens Catalyst’s reach in the cardiovascular market, a natural extension of its multi-vendor CT service expertise and long-standing relationships in cardiac imaging, while supporting Arineta’s expansion and adoption in health systems, imaging centers, and cardiology practices.
Catalyst’s sales organization will not only support Arineta’s existing qualified opportunities but also activate new sales channels, bringing the full power of its cardiology sales experience to bear, and ultimately improving access to advanced cardiac CT imaging.
This partnership serves as a model for how the Propel Partner Program helps OEMs scale faster in the U.S., providing not just service and infrastructure but also sales momentum and market access.
“We see ourselves as the catalyst for progress in diagnostic imaging—delivering value, access, and acceleration for our partners and their customers. This deepening partnership with Arineta is exactly what Propel was designed to do.”
